BRIEF-Novo Nordisk Collaborates With Multiple Authorities On Counterfeit Drug, CEO says
Novo Nordisk A/S:
* NOVO NORDISK CEO: WE ARE COLLABORATING WITH AUTHORITIES IN MULTIPLE COUNTRIES ON COUNTERFEIT SEMAGLUTIDE PROBLEM Further company coverage:
Novo Nordisk A/S:
* NOVO NORDISK CEO: WE ARE COLLABORATING WITH AUTHORITIES IN MULTIPLE COUNTRIES ON COUNTERFEIT SEMAGLUTIDE PROBLEM Further company coverage:
Google News
RSS
Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.
By submitting, you agree that we may use your email address to respond.
